ABUS Swing Long

Arbutus Biopharma CorporationNASDAQ

Opis

⋅ 4 sty 2021 20:08

ABUS have a high evaluation above 5.5$ while its currently trading at 3.6 $ expecting profiting from MRNA and PFE patent royalties , currently touching rising trend line and it could be a good entry to start accumulating

Transakcja zamknięta: osiągnięto wyznaczony cel

⋅ 21 sty 2021 19:37

take profit at 4 and 4.5

Trend Analysis Wave Analysis

Więcej